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Abstract
We recently demonstrated noninvasive detection of fetal aneuploidy by shotgun sequencing cell-free DNA in maternal
plasma using next-generation high throughput sequencer. However, GC bias introduced by the sequencer placed a
practical limit on the sensitivity of aneuploidy detection. In this study, we describe a method to computationally remove GC
bias in short read sequencing data by applying weight to each sequenced read based on local genomic GC content. We
show that sensitivity is limited only by counting statistics and that sensitivity can be increased to arbitrary precision in
sample containing arbitrarily small fraction of fetal DNA simply by sequencing more DNA molecules. High throughput
shotgun sequencing of maternal plasma DNA should therefore enable noninvasive diagnosis of any type of fetal
aneuploidy.
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Introduction
Current diagnosis of fetal aneuploidy is based on karyotyping
fetal cells obtained from amniocentesis or chorionic villus
sampling. These invasive procedures can potentially result in
miscarriages [1]. The discovery of fetal cells and cell-free fetal
nucleic acids in maternal blood in the past few decades have
prompted researchers to seek for methods to diagnose fetal
aneuploidy noninvasively. However, the small amount of fetal
genetic material relative to the maternal counterparts in maternal
blood poses a technical challenge for such task [2].
We recently achieved noninvasive detection of fetal aneuploidy
[3]. The technique uses high-throughput shotgun sequencing of
maternal plasma cell-free DNA, of which a small fraction originates
from the fetus, followed by mapping short sequence tags to the
chromosome of origin. The ability to count millions of DNA
sequences allowed us to detect small changes in the representation
of chromosomes contributed by an aneuploid fetus in a maternal
plasma sample. We successfully detected over-representation of
chromosomes 13, 18, and 21 in the respective cases trisomy 13, 18,
and 21 pregnancies, and under-representation of chromosome X in
male pregnancies. Our results were quickly reproduced by an
independent group [4,5], which used a slightly different statistical
approach in determining the representation of chromosomes. In
principle, both techniques should reveal deviation of copy number
from normal for any chromosome given sufficient amount of
counting. However, both our results and those of the independent
group deviatedfrom idealcounting statistics.Suchdeviation,caused
largely by GC bias in the sequencing data, placed a practical limit
on the sensitivity of the test especially for detecting aneuploidy
associated with chromosomes that are GC-poor or GC-rich [3].
Our observations indicated that GC bias among samples was more
substantial between sequencing runs than within runs, suggesting
that such bias might have been introduced during the sequencing
process, perhaps through slight differences in reagent composition
and temperatures that led to differences in DNA denaturation and
primer hybridization efficiency.
Here, we describe a method to computationally remove GC
bias in short read sequencing data and reanalyze the data from our
previous work. This treatment of the data eliminates most variance
in the distribution of sequence tag counts across the genome and
enables the detection of fetal aneuploidy with greater statistical
confidence. The current sensitivity is limited only by counting
statistics, and therefore it should be possible to increase the
sensitivity of noninvasive detection of any type of fetal aneuploidy
to arbitrary precision for maternal sample containing arbitrarily
small fetal DNA fraction, simply by sequencing more molecules.
Since there are measurable amounts of fetal DNA in maternal
plasma as early as day 18 after embryo transfer by assisted
reproduction [6], this suggests that it may be possible to perform
noninvasive prenatal diagnosis for fetal aneuploidy as early as
desired in the pregnancy, and potentially at the first doctor’s visit.
Methods
Data
The data analyzed in this study was collected previously [3]. It
consisted of short (25 nucleotides) sequence tags obtained by
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 5 | e10439shotgun sequencing cell-free plasma DNA collected from 19
pregnant women on the Illumina/Solexa platform.
Removal of the effect of GC bias in the density of
sequence tags
We first investigated the relation between GC content of the
sequenced DNA fragments and the number of sequence tag. We
suspected that GC bias was introduced during PCR in library
preparation and cluster generation in the Illumina/Solexa
sequencing workflow. Because the entire DNA fragment
(content between the two adaptor sequences) but not only the
25 sequenced bases participated in the PCR while the exact
length of each sequenced fragment was not known, we chose to
calculate GC content of 20 kb non-overlapping bins across the
entire human genome. Since the human genome is made up of
isochores, which are .300 kb regions of relatively homogeneous
GC content [7], sequenced fragments lying within the isochore
would most likely have GC content similar to the isochore.
Thus, any regions much smaller than 300 kb, including the
choice of 20 kb in our analysis, should provide a rough estimate
of the GC content of each sequenced fragment. Such calculation
was performed using the hgGcPercent script of the UCSC Genome
Browser’s kent source tree. The output file contained the
coordinate of each 20 kb bin and the corresponding GC
content.
For each sample, the number of sequence tag in each 20 kb bin
was counted. The average number of sequence tag per 20 kb bin,
Mi, was calculated for every 0.1% GC content, ignoring bins with
no reads, bins with zero GC percent, and bins with over-abundant
reads. All sequence tags falling within a 20 kb bin with GC content
i were assigned weights w~
M
Mi
, where M is the global average
number of sequence tag per 20 kb. Our strategy was based on the
assumption that the sequence tags would be uniformly distributed
across the genome had there been no influence of GC content.
Figure 1 illustrates the procedure for one of the patient samples.
The weighted number of sequence tag within every 50 kb non-
overlapping window was then summed to obtain the distribution
of sequence tag density for each chromosome. The choice of 50 kb
was arbitrary but was used in our previous work.
A baseline was constructed by calculating the following
expression for the k
th 50 kb bin in the i
th chromosome:
P
s
Nk
N
s
,
where Nk is the number of sequence tag in the k
th bin, N is the
average number of sequence tag per bin in the entire genome, and
s is the number of patient samples carrying two copies of
chromosome i. The final sequence tag distributions were obtained
by normalizing the GC corrected distribution by the baseline.
Detection of fetal aneuploidy
To determine whether the copy number of a chromosome
within a patient sample deviated from normal, the sequence tag
density (i.e. number of sequence tag per 50 kb bin) distribution of
a chromosome was compared to all other chromosomes (except
chromosome Y). The null hypothesis was that two distributions
had equal mean number of sequence tags per 50 kb, while the
alternative hypothesis was that the means were unequal. The z-
statistic,
mi{mj ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
si
2
ni
z
sj
2
nj
s was calculated, where m is the mean sequence
tag density; s is the standard deviation of the distribution of
sequence tag density, and n is the number of bins, and subscript i, j
represents chromosomes i, j. Each chromosome has a different
size, thereby affecting its sensitivity of detection; the varying
number of bins n for each chromosome takes this effect into
account. We required that a chromosome to be significantly
different from all other chromosomes at level a,0.001 (two-tailed)
to be called abnormal. We employed Bonferroni correction to take
into account the 22623 multiple comparisons within each sample
(i.e. |z|. 4.756 for the null hypothesis to be rejected).
Figure 1. Illustration of the procedures used to remove GC
content dependent artifact in shotgun sequencing data using
one of the patient samples as example. (A) The number of
sequence tag per 20 kb bin is plotted against GC content of the bin. (B)
The average number of sequence tag per 20 kb is calculated for every
0.1% GC content. (C) A weight is calculated for a particular value of GC
content, such that sequence tags falling within a 20 kb bin having such
GC content would receive the same calculated weight.
doi:10.1371/journal.pone.0010439.g001
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aneuploidy detection
For a given fetal DNA fraction e, we could estimate the
sequencing depth required in order to detect deviation of
chromosome copy number from normal at some level of
confidence a. When comparing the distributions of sequence tag
densities for any two chromosomes i and j, their means would be
significantly different if
mi{mj
       
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
si
2
ni
z
sj
2
nj
s §za, where m is the mean
sequence tag density; s is the standard deviation of the distribution
of sequence tag density, ni is the number of bins for chromosome i
(chromosome of interest), nj is the number of bins for chromosome
j (i?j), and za is the z-statistic associated with the level of
confidence a. If chromosome i is abnormal and chromosome j is
normal in terms of copy number, the above expression can be
approximated as
Nbin
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2
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s  ! §za, where Nbin is the genome-
wide average of number of sequence tags within a 50 kb bin; and
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assuming normal approximation of the Poisson
distribution. Since Nbin&
Ntotal
P 23
i
ni
, where n23 denotes the number
of 50 kb bins for chromosome X, the minimum total number of
reads required (i.e. sequencing depth), Ntotal, for each sample can
be estimated as Ntotal§
4za
2
e2
1
pi
z
1
pj
  
, where pi is the proportion
of chromosome i in terms of size relative to the entire genome, or
pi~
ni
P 23
i
ni
. Because our analyses of experimental data required
that the sequence tag distribution of a chromosome to be
significantly different from all other chromosomes to be called
abnormal, in our estimation for Ntotal, nj was the number of bins of
the shortest autosomes, which was either chromosome 21 or 22.
Estimation of fraction of fetal DNA
The fraction of fetal DNA in a cell-free DNA sample can
sometimes be estimated from the final sequence tag distributions.
Since chromosome X is under-represented in male pregnancies,
the fetal DNA fraction was estimated as 21 {
N23
N
  
, where
N23
N
is
the average number of sequence tag per bin for chromosome X
normalized to the global average. The fetal DNA fraction was
estimated as 2
Ni
N
{1
  
, where
Ni
N
is the normalized average
number of sequence tag per bin for chromosome 13, 18, or 21 for
the aneuploid samples.
Results
Because the degree of GC bias was different in different sample,
each sample had its own weighting scheme. Figure 2A shows the
distribution of sequence tags across each chromosome before and
after correction for GC bias for one of the 19 samples. Applying
weighting to sequence tags depending on local GC percentage
eliminated most variations in the distribution of sequence tags
across each chromosome. Through examinations of the GC
corrected sequence tag distributions of all patient samples, we
observed consistent patterns of region specific variations. We
further removed these variations by dividing the GC corrected
sequence tag distribution of each sample by that averaged from all
samples. For any sample, if the regions with unusually large
number of sequence tags (most probably due to repeats) were
ignored (by removing 50 kb regions with greater or fewer than
1.96*standard deviation of the chromosome specific sequence tag
density), the ratio of the variance and the mean of the distribution
of sequence tag density for any chromosome in any sample was
close to 1, indicating that the sampling of sequences fundamentally
followed Poisson statistics (Figure 2B). This observation was
strengthened by comparing the cumulative distribution of
sequence tag density of each chromosome with that predicted by
the Poisson distribution (Figure 2C).
Figure 3A contains plots of the distribution of normalized
sequence tag density for each chromosome (excluding chromosome
Y) within each patient sample. For all but one male pregnancy
sample, it was obvious that the distribution of chromosome X
shifted towards the left, while the distributions of chromosomes 21,
18, and 13 for the respective cases of trisomy 21, 18, and 13 shifted
towards the right, relative to the distributions of all other
chromosomes that were present in two copies. If we required that
the copy number of a chromosome to be significantly different from
that of all other chromosomes at level a,0.001 to be flagged as
abnormal, chromosome X was under-represented as compared to a
normal female genome in all but one male pregnancy, while
chromosomes 21, 18, and 13 were over-represented in the
respective cases of trisomy 21, 18, and 13 (Figure 3B). None of
the other chromosomes in the sample set were flagged.
Since the removal of sequencing artifacts revealed that the
sampling of sequences followed the Poisson distribution, we could
estimate the total number of sequence tags (i.e the depth of
sequencing) required to detect over- or under- representation of
any chromosome at certain level of confidence given the fraction
of fetal DNA in the maternal plasma sample (Figure 4). We also
plotted the total weighted number of useful sequence tags and the
estimated fetal DNA fraction for each patient sample. For male
aneuploid cases, the estimates of fetal DNA fraction could be
obtained from chromosome X and the trisomic chromosome, and
usually were very close to each other (Table 1). We observed that
the single male pregnancy sample whose chromosome X was not
flagged as abnormal had a total number of sequence tags close to
our estimated limit for detection at level a,0.001. Thus the
inability to detect under-representation of chromosome X in that
sample was most probably due to insufficient sampling. At the
present throughput of about ,10 million useful reads per channel
on the Illumina/Solexa platform, we predict that data from a
single channel enables detection of fetal trisomy 21 at a,0.001 in
a sample containing .3.9% fetal DNA and at a,0.01 in a sample
containing .3.5% fetal DNA.
Discussion
In this communication, we demonstrate an algorithm to
compensate for GC bias in high-throughput short read sequencing
Figure 2. Removal of GC bias reveals that sampling of sequence tags closely follows the Poisson distribution. (A) Sequence tag
distribution (number of sequence tags per 50 kb bin) across each chromosome before (blue) and after (red) applying GC dependent weighting to
sequence tags, using one patient sample as example. (B) Plot of variance against mean of sequence tag density for each chromosome in every
sample. (C) Comparing the cumulative distribution of the sequence tag density against that predicted by the Poisson distribution using one patient
sample as example. The red diagonal line has a slope of 1 and an intercept of 0.
doi:10.1371/journal.pone.0010439.g002
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from maternal plasma cell-free DNA. Others have shown the
existence of substantial GC bias in Illumina/Solexa and ABI/
SOLiD sequencing [5,8,9,10], and this limits the sensitivity of the
detection of under- or over-representation of chromosomes. Our
method of removing GC bias in sequencing data reveals that the
sampling of cell-free DNA by shotgun sequencing fundamentally
obeys the statistics of counting. This implies that the difference in
representation among chromosomes within a sample, however
small, can be detected to arbitrary precision by sequencing deeply
enough. The precise definition of ‘‘deeply enough’’ is that the
number of DNA molecules counted be larger than the statistical
noise, which scales as the square root of the sampling rate.
Therefore, the only factor that limits the sensitivity is the
sequencing depth. Shotgun sequencing should be able to detect
fetal aneuploidy associated not only with chromosomes 21, 18, and
13 as shown here, but all other chromosomes as well. Rarer forms
of aneuploidy, such as partial trisomy and monosomy, should in
principle be detected using such approach provided that there is
sufficient sampling. The sensitivity would depend on the length of
the region of interest, sequencing depth, and fetal DNA fraction.
For instance, by extending our analysis of Figure 4, we predicted
that a region of ,2.2 Mb of trisomy or monosomy would be
detected given the sequencing throughput of 10 million and 10%
Figure 3. Comparing the distribution of sequence tag density of each chromosome among 19 patients after correcting for GC bias.
(A) Distributions of normalized sequence tag density for each chromosome (excluding chromosome Y) within each patient sample. Red: chromosome
21; blue: chromosome X; magenta: chromosome 18; green: chromosome 13; black: all other autosomes. For all but one (P19) male pregnancy sample,
it is obvious that the distribution of chromosome X shifts towards the left, while the distributions of chromosomes 21, 18, and 13 for the respective
cases of trisomy 21, 18, and 13 shift towards the right, relative to the distributions of all other chromosomes that are present in two copies. (B) The
sequence tag distribution of each chromosome is compared to all other chromosomes (except chromosome Y) by calculating the z-statistic. If we
require that the copy number of a chromosome to be significantly different from that of all other chromosomes at level a,0.001 to be flagged as
abnormal, chromosome X is under-represented as compared to a normal female genome in all but one male pregnancy (P19), while chromosomes
21, 18, and 13 are over-represented in the respective cases of trisomy 21, 18, and 13. Plotted here is the minimum z-statistic for each chromosome
when it is compared against 22 other chromosomes. The horizontal dashed line corresponds to the statistic associated with a,0.001.
doi:10.1371/journal.pone.0010439.g003
Figure 4. Estimation of the requirement of sequencing depth for the detection of fetal aneuploidy in cell-free plasma as a function
of fetal DNA fraction. The estimates are based on level of confidence a,0.001 for chromosomes 13, 18, 21, and X, each having different length. As
fetal DNA fraction decreases, the total number of shotgun sequences required increases. With a sequencing throughput of ,10 million sequence
reads per channel on the flowcell, trisomy 21 can be detected if .3.9% of the cell-free DNA is fetal (dashed lines). The total number of sequence tags
and the estimated fetal DNA fraction from our set of 19 patient samples are also plotted. For one of the normal male samples (P19, indicated by the
solid arrow), chromosome X was not detected as under-represented. This was probably due to insufficient sampling, as the total number of sequence
obtained for this sample was close to the limit of detection given its fetal DNA fraction.
doi:10.1371/journal.pone.0010439.g004
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and in different stages of a pregnancy [11], clinical studies would
be needed to determine the minimum fetal DNA fraction and thus
the general sequencing depth required. With the rapid advances in
sequencing technologies, deep sampling can soon be achieved at
low cost. We therefore believe that high-throughput sequencing
would eventually become a nonvinasive diagnostic test for fetal
aneuploidy.
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Table 1. Fetal DNA fraction estimated from under-representation of chromosome X in male pregnancies and over-representation
of chromosomes 13, 18, and 21 from the respective cases of trisomy 13, 18 and 21.
Patient Sample Fetal DNA Fraction estimated from
chr13 chr18 chr21 chrX
P13 (46XY, 18 wk) - - - 0.10
P19 (46XY, 18 wk) - - - 0.07
P23 (46XY, 10 wk) - - - 0.11
P26 (46XY, 13 wk) - - - 0.19
P31 (46XY, 20 wk) - - - 0.12
P40 (46XY, 11 wk) - - - 0.18
P42 (46XY, 11 wk) - - - 0.08
P1 (47XX +21, 35 wk) - - 0.30 -
P2 (47XY +21, 18 wk) - - 0.17 0.17
P6 (47XX +21, 14 wk) - - 0.21 -
P7 (47XY +21, 18 wk) - - 0.32 0.31
P14 (47XX +21, 23 wk) - - 0.30 -
P17 (47XX +21, 16 wk) - - 0.10 -
P20 (47XY +21, 18 wk) - - 0.12 0.11
P52 (47XY +21, 25 wk) - - 0.24 0.25
P53 (47XX +21, 19 wk) - - 0.24 -
P57 (47XX +18, 23 wk) - 0.19 - -
P59 (47XY +18, 21 wk) - 0.39 - 0.42
P64 (47XY +13, 17 wk) 0.11 - - 0.09
doi:10.1371/journal.pone.0010439.t001
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